Tradestie Institutional Equity Comparison Engine
RBOT.WS vs ENOV โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENOV Overall Edge
ENOV Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enovis Corporation (ENOV) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RBOT.WS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ENOV at 7.3x Forward P/E and 4.0% operating margin (+1.8% YoY). In options structure, RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENOV sits in UNCLASSIFIED (43rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ENOV
RBOT.WS N/M vs ENOV 7.3x Fwd P/E
Growth & Margin Winner
ENOV
Op Margin N/A vs 4.0% ยท YoY N/A vs +1.8%
Momentum & Technical Winner
ENOV
1Y -67.2% vs -6.3% ยท 52W Pos 0% vs 59%
Options & Structure Winner
ENOV
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (43rd %ile IV)
RBOT.WS
NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap
N/A
1M Return
-67.2%
1Y Return
-67.2%
Forward P/E
N/M
Unified AI Score
50.1 / 100
HOLD
Tech 40.0
Fund 46.0
Flow 50.0
Mom 50.0
ENOV
NYSE
Enovis Corporation
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$25.47
-2.9% 1D
Market Cap
$1.5B
1M Return
+17.97%
1Y Return
-6.26%
Forward P/E
7.3x
Unified AI Score
30.0 / 100
SELL
Tech 15.0
Fund 28.0
Flow 50.0
Mom 21.3
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RBOT.WS -67.2%
ENOV -6.26%
Spread: +65.93 pp (ENOV Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RBOT.WS TTM Op. Margin: N/A
ENOV TTM Op. Margin: 4.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBOT.WS vs ENOV. Trailing 12-month operating profitability (RBOT.WS N/A vs ENOV 4.0%) and valuation multiples (RBOT.WS N/M vs ENOV 7.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RBOT.WS | ENOV | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $1.5B | Larger Scale | ENOV |
| Trailing P/E Ratio Valuation | N/M | 7.5x | Lower Multiple | ENOV |
| Forward P/E Ratio Valuation | N/M | 7.3x | Lower Multiple | ENOV |
| Revenue Growth (YoY) Growth | N/A | +1.8% | Higher Growth | ENOV |
| Operating Margin (TTM) Profitability | N/A | 4.0% | Higher Margin | ENOV |
| Net Profit Margin Profitability | N/A | -22.9% | Higher Margin | ENOV |
| Return on Equity (ROE) Capital Efficiency | N/A | -29.9% | Higher ROE | ENOV |
| 52-Week Range Position Momentum | 0% ($0โ$0) | 59% ($17โ$32) | Stronger Trend | ENOV |
| Beta / 30D Volatility Risk Regime | N/A | 0.75ฮฒ ยท 101% Vol | Lower Realized Risk | ENOV |
| Unified Institutional Score Composite Signal | 50.1 / 100 (HOLD) | 30.0 / 100 (SELL) | Higher Composite | RBOT.WS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RBOT.WS vs ENOV Buy Guide
RBOT.WS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ENOV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
43rd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RBOT.WS nor ENOV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.